How effective are rescue H. pylori eradication therapies in patients with dyspepsia?
Gisbert
Javier P
JP
Gastroenterololgy Unit, La Princesa University Hospital, Madrid, Spain. gisbert@meditex.es
D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000892:Anti-Infective Agents, Urinary / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000209:etiology* / Q000382:microbiology; D005664:Furazolidone / Q000627:therapeutic use*; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D054328:Proton Pump Inhibitors; D017828:Rifabutin / Q000627:therapeutic use*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D000892:Anti-Infective Agents, Urinary; D054328:Proton Pump Inhibitors; D017828:Rifabutin; D005664:Furazolidone; D000658:Amoxicillin